Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity.

Jiung-Chih Chao, Sheen-Yie Fang
Author Information
  1. Jiung-Chih Chao: Department of Otolaryngology, National Cheng Kung University Hospital, No. 138, Sheng Li Road, Tainan 704, Taiwan. chaojc@mail.ncku.edu.tw

Abstract

The present study was undertaken to compare positive rate of immunostaining (PR) and positive intensity of immunostaining (PI) of epidermal growth factor receptor (EGFR) in inverted papilloma (IP), synchronous carcinoma with IP and metachronous carcinoma with IP of the nasal cavity. Ten subjects with nasal polyps, ten subjects with inverted papilloma (IP), five subjects with synchronous carcinoma with IP and ten subjects with metachronous carcinoma with IP were enrolled with a control group of ten subjects of inferior turbinate. Each specimen was divided into two portions: one for RNA isolation and the other for detection of EGFR protein. Positive rate of immunostaining, positive intensity of immunostaining for EGFR protein and EGFR mRNA were significantly up-regulated in the IP, synchronous carcinoma with IP and metachronous carcinoma with IP when comparing polyp and normal mucosa. A role for EGFR in the malignant transformation from IP to SCC of the nasal cavity is suggested.

References

  1. Cancer Res. 1993 Aug 1;53(15):3579-84 [PMID: 8339264]
  2. Jpn J Cancer Res. 1994 Jun;85(6):567-71 [PMID: 8063608]
  3. Arch Otolaryngol Head Neck Surg. 2002 May;128(5):578-82 [PMID: 12003591]
  4. Mod Pathol. 2002 Mar;15(3):279-97 [PMID: 11904343]
  5. Cancer. 1992 Jan 15;69(2):358-62 [PMID: 1728365]
  6. Cancer Res. 2001 Jun 1;61(11):4490-6 [PMID: 11389080]
  7. Oncology. 2001;61(4):284-92 [PMID: 11721175]
  8. Int J Cancer. 1991 Nov 11;49(5):738-43 [PMID: 1657798]
  9. J Otolaryngol. 1979 Apr;8(2):171-8 [PMID: 430583]
  10. Head Neck. 2003 Jan;25(1):67-73 [PMID: 12478546]
  11. Am J Respir Crit Care Med. 2001 Feb;163(2):511-6 [PMID: 11179132]
  12. Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):95-8 [PMID: 17413409]
  13. Hum Pathol. 1994 May;25(5):443-8 [PMID: 8200637]
  14. Oncology. 1998 Mar-Apr;55(2):168-73 [PMID: 9499192]
  15. J Cell Biochem. 1998 Apr 1;69(1):55-62 [PMID: 9513046]
  16. Head Neck. 1998 Jul;20(4):320-7 [PMID: 9588705]
  17. Acta Otolaryngol. 1998 Jun;118(3):428-31 [PMID: 9655222]
  18. Cancer Res. 1994 Jun 15;54(12):3153-9 [PMID: 8205534]
  19. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3081-6 [PMID: 10077640]
  20. J Allergy Clin Immunol. 2000 Oct;106(4):705-12 [PMID: 11031341]
  21. Anticancer Res. 1993 Nov-Dec;13(6B):2541-51 [PMID: 8135494]
  22. Ann Otol Rhinol Laryngol. 1971 Apr;80(2):192-206 [PMID: 4323842]
  23. Laryngoscope. 1993 Jan;103(1 Pt 1):42-52 [PMID: 8421418]
  24. Clin Otolaryngol Allied Sci. 1991 Oct;16(5):466-9 [PMID: 1742894]
  25. Eur Arch Otorhinolaryngol. 1993;249(8):478-81 [PMID: 8442944]
  26. J Allergy Clin Immunol. 2001 Jun;107(6):1046-50 [PMID: 11398083]
  27. Otolaryngol Head Neck Surg. 1990 Sep;103(3):457-61 [PMID: 2122378]
  28. Laryngoscope. 1995 Feb;105(2):178-83 [PMID: 8544600]
  29. Cancer. 1996 Sep 15;78(6):1284-92 [PMID: 8826952]

MeSH Term

Carcinoma, Squamous Cell
Cell Transformation, Neoplastic
ErbB Receptors
Humans
Immunohistochemistry
Nasal Cavity
Neoplasms, Multiple Primary
Neoplasms, Second Primary
Nose Neoplasms
Papilloma, Inverted
Reverse Transcriptase Polymerase Chain Reaction

Chemicals

ErbB Receptors

Word Cloud

Created with Highcharts 10.0.0IPcarcinomaEGFRsubjectsimmunostainingnasalpositiveinvertedpapillomasynchronousmetachronouscavitytenrateintensityepidermalgrowthfactorreceptorproteinpresentstudyundertakencomparePRPITenpolypsfiveenrolledcontrolgroupinferiorturbinatespecimendividedtwoportions:oneRNAisolationdetectionPositivemRNAsignificantlyup-regulatedcomparingpolypnormalmucosarolemalignanttransformationSCCsuggestedExpressionsquamouscell

Similar Articles

Cited By